Community projects within Track 2 of the 2027 Impact Grants cycle will focus on cancer prevention and early detection in rural communities. Cancer is one of the top five leading causes of death in rural America, and rural residents have higher cancer death rates than urban residents. To reduce these disparities, we invite applications focused on cancer prevention and early detection in rural communities from organizations located in the communities they serve. All cancer types are eligible.
Application guidelines at a glance:
Timeline
Award Amount Grants will be awarded for two years at $50,000 per year, for a total of $100,000.
👉 Treatment-only oncology projects → low success probability
Successful proposals:
👉 Key question:
“Will this help prevent cancer or detect it earlier?”
👉 Pure lab science without application is less competitive
High success areas include:
👉 Innovation must be practical and scalable
👉 Equity-focused proposals have a clear advantage
👉 Programs with community trust and partnerships score higher
👉 Career development is a key evaluation factor
👉 Overly ambitious projects are often rejected
👉 Projects with clear next-step funding pathways score higher
👉 Broader impact improves competitiveness
Highest impact factors:
Moderate predictors:
4. Innovation (screening, risk prediction)
5. Health equity relevance
6. Early-career development
Supporting factors:
7. Feasibility (pilot scale)
8. Community engagement
9. Future funding potential
Compared to other cancer funders:
👉 Winning formula:
Prevention/early detection idea + real-world application + measurable population benefit
✔️ What wins:
❌ What struggles:
• Applicants must be located in rural areas
• Applicants must be exempt under Section 501(c)3 of the Internal Revenue Code or be an independent sponsored project of a nonprofit 501(c)3 organization acting as a fiscal sponsor
• Applicants may be government and public agencies
• Applicants may be tax-exempt tribal organizations and fraternal or social organizations
• Applicants must be located in the United States, including tribes or territories. Groups located outside the United States are not eligible to apply.
• Applicants must have operating budgets between $1 million and $8 million
Sponsor Institute/Organizations: Prevent Cancer Foundation
Sponsor Type: Corporate/Non-Profit
Address: 333 John Carlyle Street, Suite 635 Alexandria, VA 22314
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
May 20, 2026
$50,000
Affiliation: Prevent Cancer Foundation
Address: 333 John Carlyle Street, Suite 635 Alexandria, VA 22314
Website URL: https://preventcancer.org/education-outreach/community-grants/community-grants-community-projects/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.